v3.26.3
Revenue
12 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue

NOTE P – REVENUE

Trade receivables

Trade receivables are defined as receivables arising from contracts with customers and are recorded within the accounts receivable, net caption within the Consolidated Balance Sheets. Ashland’s trade receivables were $208 million and $200 million as of September 30, 2026 and 2025, respectively. See Note H for additional information on Ashland's program to sell certain accounts receivable on a revolving basis to third party banks up to an aggregate purchase limit.

Disaggregation of revenue

Ashland disaggregates its revenue from contracts with customers by reportable segment and geographical region, as Ashland believes these categories best depict how management reviews the financial performance of its operations. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation. See the following tables for details (Intersegment sales eliminations have been excluded, see Note Q for additional information) for the years ended September 30:

Sales by geography

 

(In millions)

 

2026

 

 

2025

 

 

2024

 

Life Sciences

 

North America

 

$

125

 

 

$

117

 

 

$

241

 

Europe

 

 

251

 

 

 

240

 

 

 

269

 

Asia Pacific

 

 

216

 

 

 

207

 

 

 

225

 

Latin America & other

 

 

79

 

 

 

77

 

 

 

75

 

 

 

$

671

 

 

$

641

 

 

$

810

 

 

 

 

 

 

 

 

 

 

 

(In millions)

 

2026

 

 

2025

 

 

2024

 

Personal Care

 

North America

 

$

148

 

 

$

155

 

 

$

183

 

Europe

 

 

226

 

 

 

219

 

 

 

238

 

Asia Pacific

 

 

143

 

 

 

128

 

 

 

128

 

Latin America & other

 

 

75

 

 

 

75

 

 

 

85

 

 

 

$

592

 

 

$

577

 

 

$

634

 

 

 

 

 

 

 

 

 

 

 

(In millions)

 

2026

 

 

2025

 

 

2024

 

Specialty Additives

 

North America

 

$

172

 

 

$

177

 

 

$

183

 

Europe

 

 

173

 

 

 

178

 

 

 

208

 

Asia Pacific

 

 

131

 

 

 

128

 

 

 

153

 

Latin America & other

 

 

28

 

 

 

28

 

 

 

28

 

 

 

$

504

 

 

$

511

 

 

$

572

 

 

 

 

 

 

 

 

 

 

 

(In millions)

 

2026

 

 

2025

 

 

2024

 

Intermediates

 

North America

 

$

89

 

 

$

90

 

 

$

103

 

Europe

 

 

23

 

 

 

26

 

 

 

21

 

Asia Pacific

 

 

15

 

 

 

14

 

 

 

16

 

Latin America & other

 

 

8

 

 

 

7

 

 

 

4

 

 

 

$

135

 

 

$

137

 

 

$

144

 

 

 

 

 

 

 

 

 

 

 

 

Ashland has two product categories that represented 10% or greater of Ashland's total consolidated sales, which were cellulosics and polyvinylpyrrolidones ("PVP"). The following table summarizes the percentage of Ashland's total consolidated sales by product:

Sales by product

 

(In millions)

 

2026

 

 

2025

 

 

2024

 

Cellulosics

 

 

40

%

 

 

39

%

 

 

37

%

PVP

 

 

24

%

 

 

25

%

 

 

23

%

 

 

64

%

 

 

64

%

 

 

60

%